Allianz Asset Management Gmb H Seres Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$5.46 - $22.6 $401,075 - $1.66 Million	-73,457 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $182,975 - $241,456	-9,912 Reduced 11.89%	73,457 $1.75 Million
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $941,401 - $1.54 Million	53,307 Added 177.32%	83,369 $1.72 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $3,092 - $5,018	-133 Reduced 0.44%	30,062 $737,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $112,929 - $867,804	30,195 New	30,195 $855,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.